Increased risk of cancer and cancer-related mortality in middle-aged Korean women with prediabetes and diabetes: a population-based study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: This study investigated the risk of developing and dying from all types of cancer, as well as cancer-specific mortality, in women diagnosed with prediabetes and diabetes. METHODS: We included women aged ≥40 years who underwent cancer screening from 2009 to 2014 with follow-up until 2020. Diabetes status was determined based on fasting plasma glucose levels, self-reported history of diabetes, and the use of antidiabetic medication. We quantified the risk of cancer and mortality in the prediabetes and diabetes groups, relative to the normoglycemia group, by calculating adjusted hazard ratios (aHRs). RESULTS: The study included 8,309,393 participants with a mean age of 52.7±9.7 years. Among these participants, 522,894 cases of cancer and 193,283 deaths were detected. An increased risk of cancer was observed in both the prediabetes group (aHR, 1.03; 95% confidence interval [CI], 1.02 to 1.04) and the diabetes group (aHR, 1.13; 95% CI, 1.12 to 1.14). The highest risk was identified in those with diabetes who developed liver (aHR, 1.72; 95% CI, 1.66 to 1.79), pancreatic (aHR, 1.68; 95% CI, 1.60 to 1.76), and gallbladder cancer (aHR, 1.43; 95% CI, 1.36 to 1.51). Women with prediabetes and diabetes exhibited a 1.07-fold (95% CI, 1.05 to 1.08) and 1.38-fold (95% CI, 1.36 to 1.41) increased risk of death from cancer, respectively. CONCLUSIONS: Both prediabetes and diabetes were associated with an elevated risk of cancer, as well as an increased risk of death from cancer, in middle-aged Korean women. However, the degree of risk varied depending on the specific site of the cancer.
Abstract
OBJECTIVES: This study investigated the risk of developing and dying from all types of cancer, as well as cancer-specific mortality, in women diagnosed with prediabetes and diabetes. METHODS: We included women aged ≥40 years who underwent cancer screening from 2009 to 2014 with follow-up until 2020. Diabetes status was determined based on fasting plasma glucose levels, self-reported history of diabetes, and the use of antidiabetic medication. We quantified the risk of cancer and mortality in the prediabetes and diabetes groups, relative to the normoglycemia group, by calculating adjusted hazard ratios (aHRs). RESULTS: The study included 8,309,393 participants with a mean age of 52.7±9.7 years. Among these participants, 522,894 cases of cancer and 193,283 deaths were detected. An increased risk of cancer was observed in both the prediabetes group (aHR, 1.03; 95% confidence interval [CI], 1.02 to 1.04) and the diabetes group (aHR, 1.13; 95% CI, 1.12 to 1.14). The highest risk was identified in those with diabetes who developed liver (aHR, 1.72; 95% CI, 1.66 to 1.79), pancreatic (aHR, 1.68; 95% CI, 1.60 to 1.76), and gallbladder cancer (aHR, 1.43; 95% CI, 1.36 to 1.51). Women with prediabetes and diabetes exhibited a 1.07-fold (95% CI, 1.05 to 1.08) and 1.38-fold (95% CI, 1.36 to 1.41) increased risk of death from cancer, respectively. CONCLUSIONS: Both prediabetes and diabetes were associated with an elevated risk of cancer, as well as an increased risk of death from cancer, in middle-aged Korean women. However, the degree of risk varied depending on the specific site of the cancer.
참고문헌 (41)
- Shi Y, "The global implications of diabetes and cancer", Lancet, 383, pp.1947~1948 (2014)
- Tsilidis KK, "Type 2 diabetes and cancer : umbrella review of meta-analyses of observational studies", BMJ, 350, pp.g7607~ (2015)
- Giovannucci E, "Diabetes and cancer : a consensus report", Diabetes Care, 33, pp.1674~1685 (2010)
- Yuan S, "Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study", Diabetes, 69, pp.1588~1596 (2020)
- Harding JL, "Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015", Diabetologia, 63, pp.75~84 (2020)
- Islam Z, "Prediabetes, diabetes, and the risk of all-cause and cause-specific mortality in a Japanese working population : Japan Epidemiology Collaboration on Occupational Health Study", Diabetes Care, 44, pp.757~764 (2021)
- Hwangbo Y, "Incidence of diabetes after cancer development : a Korean national cohort study", JAMA Oncol, 4, pp.1099~1105 (2018)
- Huang Y, "Prediabetes and the risk of cancer : a meta-analysis", Diabetologia, 57, pp.2261~2269 (2014)
- Islam Z, "Prediabetes, diabetes, and the risk of all-cause and cause-specific mortality in a Japanese Working population : Japan Epidemiology Collaboration on Occupational Health Study", Diabetes Care, 44, pp.757~764 (2021)
- Yip WC, "Prevalence of pre-diabetes across ethnicities : a review of impaired fasting glucose(IFG)and impaired glucose tolerance(IGT)for classification of dysglycaemia", Nutrients, 9, pp.1273~ (2017)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- American Diabetes Association Professional Practice Committee, "2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022", Diabetes Care, 45(Suppl 1), pp.S17~S38 (2022)
- 양민수, "Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea", Cancer Research and Treatment, 54(2), pp.352~361 (2022), 대한암학회[DOI]
- Rao Kondapally Seshasai S, "Diabetes mellitus, fasting glucose, and risk of cause-specific death", N Engl J Med, 364, pp.829~841 (2011)
- Coughlin SS, "Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults", Am J Epidemiol, 159, pp.1160~1167 (2004)
- Carreras-Torres R, "The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study", J Natl Cancer Inst, 109, pp.djx012~ (2017)
- Kim NH, "Glycemic status, insulin resistance, and risk of pancreatic cancer mortality in individuals with and without diabetes", Am J Gastroenterol, 115, pp.1840~1848 (2020)
- He J, "The association of diabetes with colorectal cancer risk : the Multiethnic Cohort", Br J Cancer, 103, pp.120~126 (2010)
- Seong-Geun Moon, "The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study", 예방의학회지, 55(5), pp.475~484 (2022), 대한예방의학회
- Xu J, "Association between markers of glucose metabolism and risk of colorectal cancer", BMJ Open, 6, pp.e011430~ (2016)
- Zheng J, "Prediabetes and diabetes in relation to risk of gastric adenocarcinoma", Br J Cancer, 120, pp.1147~1152 (2019)
- Tseng CH, "Diabetes and gastric cancer : the potential links", World J Gastroenterol, 20, pp.1701~1711 (2014)
- Gu J, "Type 2 diabetes mellitus and risk of gallbladder cancer : a systematic review and meta-analysis of observational studies", Diabetes Metab Res Rev, 32, pp.63~72 (2016)
- Das BK, "Impact of diabetes on the increased risk of hepatic cancer : an updated review of biological aspects", Diabetes Epidemiol Manag, 4, pp.100025~ (2021)
- Larsson SC, "Diabetes mellitus and risk of breast cancer : a meta-analysis", Int J Cancer, 121, pp.856~862 (2007)
- Park YM, "A prospective study of type 2 diabetes, metformin use, and risk of breast cancer", Ann Oncol, 32, pp.351~359 (2021)
- Harding JL, "Cancer risk among people with type 1 and type 2 diabetes : disentangling true associations, detection bias, and reverse causation", Diabetes Care, 38, pp.264~270 (2015)
- Chen S, "The association between diabetes", hyperglycemia and the prognosis of cervical cancer patients: a systematic review and meta-analysis, 2017, pp.96, e7981~
- Akhavan S, "Impact of diabetes mellitus on epithelial ovarian cancer survival", BMC Cancer, 18, pp.1246~ (2018)
- Bao C, "Diabetes mellitus and incidence and mortality of kidney cancer : a meta-analysis", J Diabetes Complications, 27, pp.357~364 (2013)
- Graff RE, "Type 2 diabetes in relation to the risk of renal cell carcinoma among men and women in two large prospective cohort studies", Diabetes Care, 41, pp.1432~1437 (2018)
- Lee JE, "Reproductive factors and risk of renal cell cancer : the Nurses’ Health Study", Am J Epidemiol, 169, pp.1243~1250 (2009)
- Yang WS, "Pre-existing type 2 diabetes and risk of lung cancer : a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai", BMJ Open, 4, pp.e004875~ (2014)
- Leiter A, "Assessing the association of diabetes with lung cancer risk", Transl Lung Cancer Res, 10, pp.4200~4208 (2021)
- Luo J, "Pre-existing diabetes and lung cancer prognosis", Br J Cancer, 115, pp.76~79 (2016)
- Khateeb J, "Diabetes and lung disease : a neglected relationship", Rev Diabet Stud, 15, pp.1~15 (2019)
- Yeo Y, "Diabetes mellitus and risk of thyroid cancer : a meta-analysis", PLoS One, 9, pp.e98135~ (2014)
- Luo J, "Diabetes, diabetes treatment, and risk of thyroid cancer", J Clin Endocrinol Metab, 101, pp.1243~1248 (2016)
- Seo YG, "The association between type 2 diabetes mellitus and thyroid cancer", J Diabetes Res, 2017, pp.5850879~ (2017)
- 정찬희, "Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status", Diabetes and Metabolism Journal, 45(1), pp.1~10 (2021), 대한당뇨병학회[DOI]
- Jung Yoon-Sun, "Measuring the Burden of Disease in Korea, 2008-2018", 예방의학회지, 54(5), pp.293~300 (2021), 대한예방의학회[DOI]